Amortization of Intangible Assets of TherapeuticsMD, Inc. from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
TherapeuticsMD, Inc. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • TherapeuticsMD, Inc. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $32,000.
  • TherapeuticsMD, Inc. annual Amortization of Intangible Assets for 2023 was $483,500.
  • TherapeuticsMD, Inc. annual Amortization of Intangible Assets for 2020 was $269,546, a 36% increase from 2019.
  • TherapeuticsMD, Inc. annual Amortization of Intangible Assets for 2019 was $197,593, a 76% increase from 2018.
Source SEC data
View on sec.gov
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

TherapeuticsMD, Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $32,000 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q1 2025 $88,000 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q2 2020 $239,549 $67,748 +$19,245 +40% 01 Apr 2020 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $220,304 $63,155 +$22,711 +56% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $197,593 $57,387 +$22,036 +62% 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $175,557 $51,259 +$20,159 +65% 01 Jul 2019 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $155,398 $48,503 +$23,677 +95% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $131,721 $40,444 +$19,247 +91% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $112,474 $35,351 +$16,156 +84% 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2021 2020 FY
Q3 2018 $96,318 $31,100 +$12,667 +69% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $83,651 $24,826 +$7,037 +40% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $76,614 $21,197 +$5,098 +32% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $71,516 $19,195 +$3,210 +20% 01 Oct 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
Q3 2017 $68,306 $18,433 +$4,516 +32% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $63,790 $17,789 +$4,380 +33% 01 Apr 2017 30 Jun 2017 10-Q 30 Jul 2018 2018 Q2
Q1 2017 $59,410 $16,099 +$4,865 +43% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q4 2016 $54,545 $15,985 +$5,840 +58% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $48,705 $13,917 +$5,225 +60% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $43,480 $13,409 +$6,496 +94% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $36,984 $11,234 +$4,543 +68% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $32,441 $10,145 +$3,861 +61% 01 Oct 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
Q3 2015 $28,580 $8,692 +$3,067 +55% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $25,513 $6,913 +$1,288 +23% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $24,225 $6,691 +$745 +13% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $23,480 $6,284 +$5,786 +1162% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
Q3 2014 $17,694 $5,625 +$2,370 +73% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $15,324 $5,625 +$2,370 +73% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $12,954 $5,946 +$2,692 +83% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $10,262 $498 -$28,278 -98% 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $38,540 $3,255 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $3,255 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $3,254 -$4,316 -57% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014 2014 Q1
Q4 2012 $28,776 01 Oct 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
Q1 2012 $7,570 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1

TherapeuticsMD, Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $483,500 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2020 $269,546 +$71,953 +36% 01 Jan 2020 31 Dec 2020 10-K 04 Mar 2021 2020 FY
2019 $197,593 +$85,119 +76% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
2018 $112,474 +$40,958 +57% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2021 2020 FY
2017 $71,516 +$16,971 +31% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $54,545 +$22,104 +68% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $32,441 +$8,961 +38% 01 Jan 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
2014 $23,480 +$13,218 +129% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $10,262 -$18,514 -64% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $28,776 -$383 -1.3% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $29,159 01 Jan 2011 31 Dec 2011 10-K 05 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.